Approval · Notice of Compliance 1037 · 2000
NU-CEFACLOR: Notice of Compliance 1037
Issued September 6, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1037
- Date
- September 6, 2000
- Company
- Nu-Pharm IncVaughan, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- New dosage form
- Therapeutic class
- Antibiotic
- Canadian reference product
- CECLOR (Eli Lilly Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NU-CEFACLOR | 02238049 | Cancelled (Unreturned Annual) |
| NU-CEFACLOR | 02238050 | Cancelled (Unreturned Annual) |
| NU-CEFACLOR | 02238051 | Cancelled (Unreturned Annual) |